Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Steroid Biochem Mol Biol ; 242: 106527, 2024 09.
Artículo en Inglés | MEDLINE | ID: mdl-38710312

RESUMEN

Methyltestosterone (MT) is one of the most frequently misused anabolic androgenic steroids detected in doping control analysis. The metabolism of MT in humans leads to several phase І metabolites and their corresponding phase Ⅱ conjugates. Previous studies have postulated the 3α-sulfoconjugate of 17α-methyl-5ß-androstane-3α,17ß-diol (S2) as principal sulfate metabolite of MT, with a detection window exceeding 10 days. However, a final direct and unambiguous confirmation of the structure of this metabolite is missing until now. In this study, we established an approach to detect and identify S2, using intact analysis by liquid chromatography hyphenated with tandem mass spectrometry (LC-MS/MS) without complex sample pretreatment. An in vitro study yielded the LC-MS/MS reference retention times of all 3-sulfated 17-methylandrostane-3,17-diol diastereomers, allowing for accurate structure assignment of potentially detected metabolites. In an in vivo excretion study with a single healthy male volunteer, the presence of the metabolite S2 was confirmed after a single oral dose of 10 mg MT. The reference standard was chemically synthesized, characterized by accurate mass mass spectrometry (MS) and nuclear magnetic resonance (NMR), and quantified by quantitative NMR (qNMR). Thus, this study finally provides accurate structure information on the S2 metabolite and a direct analytical method for detection of MT misuse. The availability of the reference material is expected to facilitate further evaluation and subsequent analytical method validation in anti-doping research.


Asunto(s)
Doping en los Deportes , Metiltestosterona , Detección de Abuso de Sustancias , Espectrometría de Masas en Tándem , Masculino , Humanos , Metiltestosterona/metabolismo , Metiltestosterona/análisis , Espectrometría de Masas en Tándem/métodos , Cromatografía Liquida/métodos , Detección de Abuso de Sustancias/métodos , Doping en los Deportes/prevención & control , Anabolizantes/metabolismo , Anabolizantes/análisis , Adulto , Cromatografía Líquida con Espectrometría de Masas
2.
Chembiochem ; 21(18): 2615-2619, 2020 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-32315494

RESUMEN

The family of NAD(P)H-dependent short-chain dehydrogenases/reductases (SDRs) comprises numerous biocatalysts capable of C=O or C=C reduction. The highly homologous noroxomaritidine reductase (NR) from Narcissus sp. aff. pseudonarcissus and Zt_SDR from Zephyranthes treatiae, however, are SDRs with an extended imine substrate scope. Comparison with a similar SDR from Asparagus officinalis (Ao_SDR) exhibiting keto-reducing activity, yet negligible imine-reducing capability, and mining the Short-Chain Dehydrogenase/Reductase Engineering Database indicated that NR and Zt_SDR possess a unique active-site composition among SDRs. Adapting the active site of Ao_SDR accordingly improved its imine-reducing capability. By applying the same strategy, an unrelated SDR from Methylobacterium sp. 77 (M77_SDR) with distinct keto-reducing activity was engineered into a promiscuous enzyme with imine-reducing activity, thereby confirming that the ability to reduce imines can be rationally introduced into members of the "classical" SDR enzyme family. Thus, members of the SDR family could be a promising starting point for protein approaches to generate new imine-reducing enzymes.


Asunto(s)
Iminas/metabolismo , Cetonas/metabolismo , Deshidrogenasas-Reductasas de Cadena Corta/metabolismo , Asparagus/enzimología , Iminas/química , Cetonas/química , Methylobacterium/enzimología , Modelos Moleculares , Estructura Molecular , Oxidación-Reducción , Deshidrogenasas-Reductasas de Cadena Corta/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA